BusinessCyclacel Announces Notice of Grant of New European Patent Covering Sapacitabine Pharmaceutical FormulationsBy Nasdaq OMXFeb 21, 2018, 12:03 PM UTC
BusinessCyclacel Announces Presentation of Results From Phase 3 Seamless Study at Ash Annual MeetingBy Nasdaq OMXDec 12, 2017, 12:01 PM UTC
BusinessCyclacel Pharmaceuticals Announces That Full Results From the Phase 3 Seamless Trial Have Been Selected for Oral Presentation at ASH 2017 Annual MeetingBy Nasdaq OMXNov 1, 2017, 1:02 PM UTC
